You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 16, 2025

Drug Price Trends for NDC 82009-0100


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 82009-0100

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
No data available in table
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 0 to 0 of 0 entries

Market Analysis and Price Projections for the Drug NDC: 82009-0100

Understanding the National Drug Code (NDC)

To analyze the market and price projections for a specific drug identified by its NDC, it is crucial to understand what the NDC represents. The National Drug Code (NDC) is a unique, three-segment number that identifies a drug product. It consists of a labeler code, a product code, and a package code[1][4].

Identifying the Drug

The NDC 82009-0100 can be broken down as follows:

  • Labeler Code: The first segment identifies the labeler, which could be a manufacturer, repackager, or relabeler.
  • Product Code: The second segment identifies the specific strength, dosage form, and formulation of the drug.
  • Package Code: The third segment identifies the package size and type.

Market Context

Prescription and OTC Drugs Market

The market for prescription and over-the-counter (OTC) drugs is vast and dynamic. The U.S. OTC drugs market, for instance, is estimated to be around $42.80 billion in 2024 and is projected to grow to $53 billion by 2029, with a CAGR of 4.40%[3].

Price Trends in Prescription Drugs

Price changes in prescription drugs are a significant factor in market analysis. Historically, most price increases occur in January and July each year. From 2016 to 2022, the average price increase in January was around $150 per drug, while in July it was around $250, reflecting higher dollar increases for higher-priced drugs[5].

Price Projections

Historical Price Changes

To project future prices, understanding historical trends is essential. For the period from 2017 to 2023, the average price increase for prescription drugs varied significantly. For example, from January 2022 to January 2023, the average price increase was 15.2%, translating to a dollar increase of $589.68 per drug. This was notably higher than previous years, indicating that price increases are often concentrated in more expensive drug products[2].

Significant Price Increases

Significant price changes, defined as increases greater than $20 per package or 10% within a 12-month period, or any change greater than $500 per package, are critical for analysis. In 2022, over 3000 drugs experienced price increases, with 241 exceeding the 10% and $20 threshold in January alone[5].

Inflation and General Economic Trends

Price increases are also influenced by general inflation rates. For instance, between July 2021 and July 2022, the Consumer Price Index (CPI-U) increased by 8.5%, which affected drug price increases. Drugs that exceeded this inflation rate were more common, with an average price increase of 31.6% for those exceeding the CPI-U[5].

Specific Analysis for NDC 82009-0100

Current Pricing and Historical Data

To provide a precise analysis for the drug with NDC 82009-0100, one would need to access the current pricing and historical data from databases such as the FDA's National Drug Code Directory or market analytics platforms like AnalySource.

Market Segment and Competition

Understanding the market segment and competition for this specific drug is crucial. If it is a single-source drug, it may experience different price dynamics compared to multi-source drugs. Single-source drugs tend to have lower percentage increases but higher absolute dollar increases[2].

Regulatory and Approval Status

The FDA approval status and any recent changes in regulatory requirements can also impact pricing. For example, drugs approved under New Drug Applications (NDAs) or Abbreviated New Drug Applications (ANDAs) have undergone rigorous safety and effectiveness reviews, which can influence their pricing strategies[1].

Key Takeaways

  • NDC Structure: The NDC is a three-segment code identifying the labeler, product, and package.
  • Market Trends: Prescription and OTC drug markets are dynamic, with significant price increases often occurring in January and July.
  • Historical Price Changes: Average price increases vary by year, with recent years showing higher dollar increases for more expensive drugs.
  • Inflation Impact: General inflation rates influence drug price increases, with some drugs exceeding the CPI-U.
  • Regulatory Factors: FDA approval and regulatory changes can impact pricing strategies.

FAQs

What is the National Drug Code (NDC)?

The National Drug Code (NDC) is a unique, three-segment number that identifies a drug product, including the labeler, product, and package.

How often do prescription drug prices change?

Most price increases for prescription drugs occur in January and July each year.

What factors influence prescription drug price increases?

Factors include general inflation rates, the type of drug (single-source vs. multi-source), and regulatory changes.

How can I find historical pricing data for a specific NDC?

Historical pricing data can be found through databases such as the FDA's National Drug Code Directory or market analytics platforms.

What is the significance of FDA approval in drug pricing?

FDA approval under NDAs or ANDAs ensures the drug has undergone rigorous safety and effectiveness reviews, which can influence pricing strategies.

How does the market size of OTC drugs impact prescription drug pricing?

The high cost of prescription drugs has led to a shift towards OTC drugs, which can influence overall market dynamics and pricing strategies.

Sources

  1. FDA, "National Drug Code Database Background Information - FDA"
  2. ASPE, "Changes in the List Prices of Prescription Drugs, 2017-2023"
  3. GlobeNewswire, "U.S. OTC Drugs Market Forecast Report 2024-2029"
  4. FDA, "National Drug Code Directory - FDA"
  5. ASPE, "Price Increases for Prescription Drugs, 2016-2022"

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.